Company Filing History:
1 out of 832,891 Years Active: 2017
Title: Susanne Modrow: Innovator in Parvovirus Research
Introduction
Susanne Modrow is a notable inventor based in Altenthann, Germany. She has made significant contributions to the field of virology, particularly in her research on parvoviruses. Her work has led to advancements in understanding viral proteins and their functionalities.
Latest Patents
Susanne Modrow holds a patent for a modified VP1-capsid protein of parvovirus B19. This invention relates to a modified VP1-capsid protein that exhibits reduced phospholipase A2-like enzyme activity compared to the wild type VP1-capsid protein of parvovirus B19, which has the amino acid sequence of SeqID 1. This innovation has potential implications for therapeutic applications and further research in virology.
Career Highlights
Throughout her career, Susanne Modrow has worked with prominent organizations, including Novartis AG. Her expertise in virology and protein modification has positioned her as a key figure in her field. She has dedicated her efforts to advancing scientific knowledge and developing innovative solutions.
Collaborations
Susanne has collaborated with notable colleagues such as Torsten Lowin and Markus Mobs. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the study of parvoviruses.
Conclusion
Susanne Modrow's contributions to the field of virology, particularly through her patented work on parvovirus B19, highlight her role as an influential inventor. Her collaborations and career achievements reflect her commitment to advancing scientific research and innovation.